JAC, one of the world’s leading specialist vendors of medicines management software, has been named as one of just two firms to be awarded ‘preferred bidder’ status for a Hospital Electronic Prescribing and Medicines Administration (HEPMA) software contract by NHS Scotland.

22 August 2016 – JAC is pleased to announce that it has been accredited by NHS Scotland to deliver its Hospital Electronic Prescribing and Administration (HEPMA) to Scottish NHS Boards in a framework contract worth £15million. This contract, which is expected to be signed by the end of September, is indicative of Scotland’s commitment to digitise its health services.

JAC’s HEPMA system is an integral component of its end-to-end medicines management platform which includes the requisition, supply and administration of prescribed drugs, along with clinical decision support.

JAC’s HEPMA solution has already been deployed to great effect at four NHS Boards, helping them achieve their Scottish NHS mandated objectives for ehealth. In addition several other Scottish NHS Boards manage their pharmacy services with JAC.

JAC are delighted to have passed the evaluation and been given preferred status on the HEPMA Framework,

Robert Tysall-Blay, Chief Executive of JAC.

“The funding and focus on hospital e-prescribing as part of the Scottish e-Health Strategy 2014-2017 will certainly help delivery of one of the central aims of the strategy, which is ‘to improve the safety of people taking medicines and their effective use’.”

“We look forward to building on the work already undertaken by the Health Boards in Scotland who are currently using HEPMA from JAC and by helping other Health Boards to align their medicines management strategies with the vision laid down in NHS Scotland’s eHealth Applications strategy.”